About Vir Biotech (VIR)
Vir Biotechnology, Inc. is a clinical-stage immunology company. The Company is focused on developing treatments to treat and prevent serious infectious diseases. Its technology platforms are focused on antibodies, T cells, innate immunity and small i... Read more
- USD8.31
- USD8.50
- USD8.25
- USD27.48
- -17.50%
- 86M
- 165.96k
- 852.92k
- 1.1B
- 7.61
- -66.30%
Stock News
3 hours ago
ICE to Provide OTC Derivatives Pricing and Risk Management Solution to Multinational Mining and Metallurgy Company Eramet S.A.
Yahoo
4 hours ago
These 3 Dividend Payers Are Forever Stocks, Even if the Market Crumbles
Yahoo
4 hours ago
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Yahoo
4 hours ago
Immutep Quarterly Activities Report Q3 FY24
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
